Osaic Holdings’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3
| Closed | – | – | 7936 |
|
|
2025
Q2 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 7803 |
|
|
2025
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7562 |
|
|
2024
Q4 | $53 | Hold |
2
| – | – | ﹤0.01% | 7285 |
|
|
2024
Q3 | $75 | Hold |
2
| – | – | ﹤0.01% | 7268 |
|
|
2024
Q2 | $115 | Hold |
2
| – | – | ﹤0.01% | 7235 |
|
|
2024
Q1 | $281 | Hold |
2
| – | – | ﹤0.01% | 6916 |
|
|
2023
Q4 | $369 | Sell |
2
-88
| -98% | -$16.7K | ﹤0.01% | 6937 |
|
|
2023
Q3 | $22.4K | Buy |
90
+44
| +96% | +$16.4K | ﹤0.01% | 5495 |
|
|
2023
Q2 | $24.4K | Sell |
46
-2
| -4% | -$1.23K | ﹤0.01% | 5435 |
|
|
2023
Q1 | $36.9K | Buy |
48
+14
| +41% | +$10.3K | ﹤0.01% | 5169 |
|
|
2022
Q4 | $10K | Buy |
34
+3
| +10% | +$1.27K | ﹤0.01% | 5928 |
|
|
2022
Q3 | $16K | Buy |
31
+6
| +24% | +$3.66K | ﹤0.01% | 5747 |
|
|
2022
Q2 | $14K | Buy |
25
+2
| +9% | +$1.67K | ﹤0.01% | 5849 |
|
|
2022
Q1 | $29K | Hold |
23
| – | – | ﹤0.01% | 5449 |
|
|
2021
Q4 | $26K | Buy |
23
+6
| +35% | +$8.22K | ﹤0.01% | 5609 |
|
|
2021
Q3 | $25K | Sell |
17
-1
| -6% | -$1.6K | ﹤0.01% | 5614 |
|
|
2021
Q2 | $35K | Buy |
18
+9
| +100% | +$16.5K | ﹤0.01% | 5303 |
|
|
2021
Q1 | $17K | Buy |
9
+5
| +125% | +$11K | ﹤0.01% | 5584 |
|
|
2020
Q4 | $8K | Buy |
4
+1
| +33% | +$2.59K | ﹤0.01% | 5607 |
|
|
2020
Q3 | $8K | Buy |
3
+2
| +200% | +$7.18K | ﹤0.01% | 5378 |
|
|
2020
Q2 | $3K | Buy |
+1
| New | +$1.91K | ﹤0.01% | 5668 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6111 |
|
Osaic Holdings's HEPA Position: Q3 2025 in Review
Osaic Holdings sold out of Hepion Pharmaceuticals (HEPA) in Q3 2025, closing a stake of 3 shares.
Osaic Holdings first reported a position in HEPA in Q2 2020 and held it in 21 quarters. The position peaked at $36.9K in Q1 2023. 1 fund tracked by Wall St. Rank holds HEPA as of Q3 2025.
- Osaic Holdings reported no remaining Hepion Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Osaic Holdings sold 3 Hepion Pharmaceuticals shares in Q3 2025.
- Osaic Holdings first reported a position in Hepion Pharmaceuticals in Q2 2020 and held it in 21 quarters.
- Osaic Holdings's Hepion Pharmaceuticals position peaked at $36.9K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q3 2025.
Based on Osaic Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.